VKTX - Viking Therapeutics, Inc. Operating income before deduction of amortization

Public company logo of Viking Therapeutics Inc (VKTX)

Viking Therapeutics (VKTX) is developing a pipeline of treatments for metabolic disorders, and an analysis of the chart on GURU.Markets reveals that the operating profit (EBIT) trend features a new parameter 0.00. This development relies on AI screening to accelerate testing and the active preparation of breakthrough drugs such as VK2735, whose obesity trials are demonstrating revolutionary results.

Viking Pharma (VKTX) - Operating profit EBITDA from 11/23/2025 to 11/15/2026

Viking Therapeutics, Inc. - analytical breakdowns and key metrics (VKTX)

Summary company analytics:Viking Therapeutics
Brand item of vikingtherapeutics.com

Professional capital evaluates the profile of Viking Therapeutics (VKTX) through its ability to generate real cash flow to fund costly clinical trials. An analysis of total EBITDA allows for the exclusion of paper revenue to measure actual cash inflows, which is critical for assessing the company's survival amidst fierce competition with pharma behemoths and the risks of failure in final-phase trials.

Who Viking Therapeutics competes with

Biogen Inc. (BIIB) - Profit before interest, taxes and amortization|NBIX - Profit before payment of interest, taxes and amortization|RGC (Regencell Bioscience Holdings Limited) - Operating profit before amortization|Axsome Corp (AXSM) - Profit before payment of interest, taxes and amortization|ACAD - Operating income before deduction of amortization|Operating profit before deduction of amortization XENE|Operating profit before amortization SUPN (Supernus)|Profit before payment of interest, taxes and amortization Catalyst Pharma (CPRX)|DNLI (Denali Therapeutics Inc) - Income before deduction of interest, taxes and amortization|Harmony Pharma - Operating profit before deduction of amortization|BHVN: Operating profit before amortization|Amylyx Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization trevitherapeutics.com|PRAX: Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization AVXL (Anavex Life Sciences Corp.)|Profit before payment of interest, taxes and amortization CeriBell, Inc.|Profit before interest, taxes and amortization Prothena Biosciences PRTA|Operating profit before deduction of amortization ALEC (Alector Therapeutics)|Operating income before deduction of amortization Annexon, Inc.|Profit before payment of interest, taxes and amortization Omeros Corporation OMER|NGNE - Operating profit before deduction of amortization|ACIU - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VYGR|NMRA: Operating profit EBITDA|Scilex Holding Company - Income before deduction of interest, taxes and amortization|TVGN (Tevogen Bio Holdings, Inc.) - Operating profit EBITDA|Operating profit EBITDA Alpha Cognition|Operating profit EBITDA CGTX|IKT - Profit before interest, taxes and amortization|Operating profit EBITDA SAVA (cassavasciences.com)|Income before deduction of interest, taxes and amortization ASRT|Coya Therapeutics Inc - Operating profit EBITDA|Operating income before deduction of amortization vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Profit before payment of interest, taxes and amortization|Acumen Pharmaceuticals, Inc (ABOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization CervoMed Inc.|Alterity Therapeutics (ATHE) - Operating income before deduction of amortization|Operating profit EBITDA CLNN|PEPG - Profit before interest, taxes and amortization|Operating profit EBITDA JUNS (Jupiter Neurosciences, Inc.)|RLMD - Operating profit before deduction of amortization|ANVS - Profit before payment of interest, taxes and amortization|Operating profit before depreciation charges Grace Therapeutics (GRCE)|AIFF: Operating profit EBITDA|ANEW Medical, Inc. (KLTO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd.|RVPH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MTVA|Operating profit EBITDA NeurAxis (NRXS)|Helius Medical Technologies, Inc. - Operating profit before deduction of amortization|Operating income before deduction of amortization Passage Bio, Inc. (PASG)|Neuphoria - Operating profit EBITDA|Income before deduction of interest, taxes and amortization NERV (Minerva)|ATHA: Operating profit EBITDA|Operating profit before amortization ADXN|Operating profit before deduction of amortization ALZN|Profit before interest, taxes and amortization Cyclerion Therapeutics CYCN|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|Operating profit EBITDA Pasithea Therapeutics Corp (KTTA)|Cortigent, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Avenue Therapeutics ATXI|BCLI - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization CARA (Cara Therapeutics)|Chromocell Therapeutics Corporation (CHRO) - Profit before payment of interest, taxes and amortization|Eliem Therapeutics, Inc. - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization ITCI|Profit before interest, taxes and amortization longboardpharma.com LBPH|Profit before payment of interest, taxes and amortization Marinus (MRNS)|Company profit before taxes, interest and amortization NKGN|Operating profit EBITDA NRBO (NeuroBo)|Income before deduction of interest, taxes and amortization SAGE|SNPX: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Trevena|VIGL: Operating profit EBITDA|WENA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Cerevel